The present invention relates to esters of carboxylic acid agrochemicals comprising a labile protecting group and having formula (I). Certain of the esters of carboxylic acid agrochemicals do not undergo hydrolysis to a significant degree in the dark, but are cleaved to regenerate the parent carboxylic acid agrochemical when exposed to light. Others of the esters of carboxylic acid agrochemicals undergo hydrolysis under both light and dark conditions. The present invention further relates to methods for the controlled release of a carboxylic acid agrochemicals, and to methods of controlling unwanted plants comprising applying to the unwanted plants an ester of a carboxylic acid agrochemical.

The present invention relates to esters of carboxylic acid agrochemicals comprising a labile protecting group and having formula (I). Certain of the esters of carboxylic acid agrochemicals do not undergo hydrolysis to a significant degree in the dark, but are cleaved to regenerate the parent carboxylic acid agrochemical when exposed to light. Others of the esters of carboxylic acid agrochemicals undergo hydrolysis under both light and dark conditions. The present invention further relates to methods for the controlled release of a carboxylic acid agrochemicals, and to methods of controlling unwanted plants comprising applying to the unwanted plants an ester of a carboxylic acid agrochemical.

A composition including a compound of formula (I)

##STR00001##

and one or more mitochondrial electron transport system complex III inhibitor(s) selected from the group consisting of azoxystrobin, coumoxystrobin, enoxastrobin, flufenoxystrobin, picoxystrobin, pyraoxystrobin, pyraclostrobin, mandestrobin, pyrametostrobin, triclopyricarb, kresoxim-methyl, trifloxystrobin, dimoxystrobin, fenaminstrobin, metominostrobin, orysastrobin, famoxadone, fluoxastrobin, fenamidone, pyribencarb, metyltetraprole, cyazofamid, amisulbrom, fenpicoxamid, and florylpicoxamid.

A composition including a compound of formula (I)

##STR00001##

and one or more mitochondrial electron transport system complex III inhibitor(s) selected from the group consisting of azoxystrobin, coumoxystrobin, enoxastrobin, flufenoxystrobin, picoxystrobin, pyraoxystrobin, pyraclostrobin, mandestrobin, pyrametostrobin, triclopyricarb, kresoxim-methyl, trifloxystrobin, dimoxystrobin, fenaminstrobin, metominostrobin, orysastrobin, famoxadone, fluoxastrobin, fenamidone, pyribencarb, metyltetraprole, cyazofamid, amisulbrom, fenpicoxamid, and florylpicoxamid.

A composition suitable for control of diseases caused by phytopathogens comprising (A) a compound of formula I ##STR00001##
wherein R.sub.1 is difluoromethyl or trifluoromethyl and X is chloro, fluoro or bromo; and (B) at least one compound selected from compounds known for their fungicidal activity; and a method of controlling diseases on useful plants, especially rust diseases on soybean plants.

A composition suitable for control of diseases caused by phytopathogens comprising (A) a compound of formula I ##STR00001##
wherein R.sub.1 is difluoromethyl or trifluoromethyl and X is chloro, fluoro or bromo; and (B) at least one compound selected from compounds known for their fungicidal activity; and a method of controlling diseases on useful plants, especially rust diseases on soybean plants.

A composition suitable for control of diseases caused by phytopathogens comprising (A) a compound of formula I ##STR00001##
wherein R.sub.1 is difluoromethyl or trifluoromethyl and X is chloro, fluoro or bromo; and (B) at least one compound selected from compounds known for their fungicidal activity; and a method of controlling diseases on useful plants, especially rust diseases on soybean plants.

Disclosed is a formulation having at least two auxinic hormonal herbicides, normally used separately in applications to control a wide variety of broadleaf weeds, present in fields without cultivation, during chemical fallows, and in crops such as winter cereals, corn and sorghum, that together have a synergistic effect on weed control. This effect is even greater in the microemulsion formulation that includes at least the two active ingredients, if compared to the conventional tank mix, this greater efficiency being attributed to the chemical compatibility that exists in the “ready mix” achieved by the correct choice of emulsifiers to maintain active emulsion, physical compatibility that translates into greater biological efficacy. Preferably, the herbicidal composition has at least: (i) from 7.5% to 40% of 2,4-D in its acidic form; and (ii) from 1.2% to 35% of Dicamba in its acid formic as active ingredients, formulated together in a microemulsion type formulation.

Disclosed is a formulation having at least two auxinic hormonal herbicides, normally used separately in applications to control a wide variety of broadleaf weeds, present in fields without cultivation, during chemical fallows, and in crops such as winter cereals, corn and sorghum, that together have a synergistic effect on weed control. This effect is even greater in the microemulsion formulation that includes at least the two active ingredients, if compared to the conventional tank mix, this greater efficiency being attributed to the chemical compatibility that exists in the “ready mix” achieved by the correct choice of emulsifiers to maintain active emulsion, physical compatibility that translates into greater biological efficacy. Preferably, the herbicidal composition has at least: (i) from 7.5% to 40% of 2,4-D in its acidic form; and (ii) from 1.2% to 35% of Dicamba in its acid formic as active ingredients, formulated together in a microemulsion type formulation.

The present invention relates to methods for producing nanoparticle and microparticle powders of a biologically active material which have improved powder handling properties making the powders suitable for commercial use using dry milling processes as well as compositions comprising such materials, medicaments produced using said biologically active materials in particulate form and/or compositions, and to methods of treatment of an animal, including man, using a therapeutically effective amount of said biologically active materials administered by way of said medicaments.